InfuSystem (INFU) Announces Earnings Results
InfuSystem (NYSEAMERICAN:INFU) issued its earnings results on Tuesday. The medical instruments supplier reported ($0.03) EPS for the quarter, Morningstar.com reports. InfuSystem had a negative net margin of 0.73% and a negative return on equity of 1.06%. The company had revenue of $18.89 million during the quarter.
Shares of InfuSystem (INFU) traded down $0.06 during midday trading on Wednesday, hitting $2.30. The stock had a trading volume of 505 shares, compared to its average volume of 13,157. The firm has a market capitalization of $49.55, a P/E ratio of -16.86 and a beta of 0.15. InfuSystem has a fifty-two week low of $1.20 and a fifty-two week high of $2.45.
InfuSystem declared that its Board of Directors has initiated a stock buyback program on Tuesday, March 13th that allows the company to buyback 1,000,000 shares. This buyback authorization allows the medical instruments supplier to repurchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.
InfuSystem Company Profile
InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.